GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
26 sept. 2024 09h15 HE
|
GT Biopharma, Inc.
SAN FRANCISCO, CALIFORNIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative...